{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:21:10Z","timestamp":1792639270918,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijantimicag.2017.08.029","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T03:30:35Z","timestamp":1504582235000},"page":"299-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":216,"title":["Reactive oxygen species: a novel antimicrobial"],"prefix":"10.1016","volume":"51","author":[{"given":"Matthew","family":"Dryden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0010","author":"WHO"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0015","author":"Review on Antimicrobial Resistance"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0020","author":"Department of Health and Department for Environment, Food and Rural Affairs"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11892-006-0076-x","article-title":"The diabetic foot: the importance of biofilms and wound bed preparation","volume":"6","author":"Davis","year":"2006","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgar.2016.12.012","article-title":"Hot topics in reactive oxygen therapy: antimicrobial and immunological mechanisms, safety and clinical applications","volume":"8","author":"Dryden","year":"2017","journal-title":"J Glob Antimicrob Res"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/iwj.12557","article-title":"Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process","volume":"14","author":"Dunnill","year":"2017","journal-title":"Int Wound J"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jgar.2016.12.006","article-title":"Reactive oxygen: a novel antimicrobial mechanism for targeting biofilm-associated infection","volume":"8","author":"Dryden","year":"2017","journal-title":"J Glob Antimicrob Res"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2014.03.006","article-title":"Engineered honey: in vitro antimicrobial activity of a novel topical wound care treatment","volume":"2","author":"Dryden","year":"2014","journal-title":"J Glob Antimicrob Res"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13104-014-0960-4","article-title":"The antimicrobial activity of prototype modified honeys that generate reactive oxygen species (ROS) hydrogen peroxide","volume":"8","author":"Cooke","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.12968\/jowc.2016.25.2.93","article-title":"In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates","volume":"25","author":"Halstead","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.12968\/jowc.2016.25.3.140","article-title":"A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds","volume":"25","author":"Dryden","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jhin.2014.07.008","article-title":"Infection prevention in wounds with Surgihoney","volume":"88","author":"Dryden","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12968\/bjom.2014.22.2.111","article-title":"Bioengineered Surgihoney as an antimicrobial wound dressing to prevent Caesarean wound infection: a clinical and cost-effectiveness study","volume":"22","author":"Dryden","year":"2014","journal-title":"Br J Midwifery"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.12968\/jowc.2014.23.6.338","article-title":"The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines","volume":"23","author":"Dryden","year":"2014","journal-title":"J Wound Care"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0080","series-title":"NICE clinical guidelines No. 119: Inpatient management of diabetic foot problems","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0085","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1524-475X.2012.00836.x","article-title":"A review of the scientific evidence for biofilms in wounds","volume":"20","author":"Percival","year":"2012","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0090","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1093\/jac\/dkw287","article-title":"Antimicrobial stewardship in wound care: a position paper from the British Society for Antimicrobial Chemotherapy and European Wound Management Association","volume":"71","author":"Lipsky","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0095","first-page":"66","article-title":"Surgihoney as a novel antimicrobial coating in salvage revision total knee arthroplasty","volume":"97-B","author":"Khan","year":"2015","journal-title":"Orthop Proc"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QCO.0000000000000350","article-title":"Reactive oxygen therapy: a novel therapy in soft tissue infection","volume":"30","author":"Dryden","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib9000","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.isjp.2017.07.001","article-title":"Impact of Surgihoney Reactive Oxygen on surgical site infection (SSI) after complex abdominal wall reconstruction (AWR) of grade 3 and 4 ventral Hernias: A single arm pilot study","volume":"5","author":"Parker","year":"2017","journal-title":"International Journal of Surgery Protocols"},{"key":"10.1016\/j.ijantimicag.2017.08.029_bib0105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T23:29:37Z","timestamp":1535412577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791730328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S092485791730328X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.029","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactive oxygen species: a novel antimicrobial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}